Kawaguchi, K., Igarashi, K., Murakami, T., Kiyuna, T., Lwin, T. M., Hwang, H. K., . . . Hoffman, R. M. (2017). MEK inhibitors cobimetinib and trametinib, regressed a gemcitabine-resistant pancreatic-cancer patient-derived orthotopic xenograft (PDOX). Oncotarget.
Citación estilo ChicagoKawaguchi, Kei, et al. "MEK Inhibitors Cobimetinib and Trametinib, Regressed a Gemcitabine-resistant Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX)." Oncotarget 2017.
Cita MLAKawaguchi, Kei, et al. "MEK Inhibitors Cobimetinib and Trametinib, Regressed a Gemcitabine-resistant Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX)." Oncotarget 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.